Skip to content

HORIZON

GUIDE.MRD

GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

Programme
Horizon Europe
Started
Ends
Duration
60 months
Total cost
EUR 34,948,425
EU contribution
EUR 17,660,955
Participants
32 from 13 countries
Topic
HORIZON_HORIZON-JU-IHI-2022-01-03
Grant agreement
101112066

Coordinated by Universitaetsklinikum Hamburg-Eppendorf (DEGermany).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
Universitaetsklinikum Hamburg-EppendorfDEGermanyCoordinatorEUR 2,345,919PIC (1.00)
Medizinische Universitat GrazATAustriaParticipantEUR 1,918,230known name (0.95)
Digestive Cancers Europe DiceBEBelgiumParticipantEUR 289,750PIC (1.00)
Synergist ServicesBEBelgiumParticipantEUR 842,716PIC (1.00)
The SynergistBEBelgiumParticipantEUR 600,901PIC (1.00)
Amgen (Europe) GmbHCHSwitzerlandParticipantEUR 0PIC (1.00)
Lung Cancer Europe LuceCHSwitzerlandAssociated partnerEUR 0PIC (1.00)
Abbvie Deutschland GmbH & Co KGDEGermanyAssociated partnerEUR 0PIC (1.00)
Bristol-Myers Squibb GmbH & Co. KgaaDEGermanyAssociated partnerEUR 0PIC (1.00)
Lungenclinic Grosshansdorf GmbHDEGermanyParticipantEUR 765,364known name (0.97)
Aarhus UniversitetDKDenmarkParticipantEUR 1,142,500known name (0.95)
Aarhus UniversitetshospitalDKDenmarkParticipantEUR 2,701,344known name (0.95)
Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos IIIESSpainParticipantEUR 1,272,889VAT number (0.97)
Bristol-Myers Squibb SASFRFranceAssociated partnerEUR 0PIC (1.00)
Centre Hospitalier Universitaire de NiceFRFranceParticipantEUR 719,625known name (0.95)
Centre Hospitalier Universitaire MontpellierFRFranceParticipantEUR 1,385,764PIC (1.00)
Astrazeneca UK LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Horizon Discovery LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Illumina Cambridge LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Innovation Acta SRLITItalyParticipantEUR 377,734PIC (1.00)
Academisch Ziekenhuis GroningenNLNetherlandsParticipantEUR 1,513,496PIC (1.00)
Bristol-Myers Squibb B.V.NLNetherlandsAssociated partnerEUR 0PIC (1.00)
Asociatia Centrul Pentru Inovatie in MedicinaRORomaniaParticipantEUR 276,250PIC (1.00)
Karolinska InstitutetSESwedenParticipantEUR 655,138known name (0.95)
Region StockholmSESwedenParticipantEUR 853,336known name (0.95)
Abbvie IncUSUnited StatesParticipantEUR 0PIC (1.00)
Amgen IncUSUnited StatesAssociated partnerEUR 0PIC (1.00)
AstraZeneca Pharmaceuticals LPUSUnited StatesAssociated partnerEUR 0PIC (1.00)
Bristol-Myers Squibb Company CorpUSUnited StatesParticipantEUR 0PIC (1.00)
E.R. Squibb & Sons LLCUSUnited StatesAssociated partnerEUR 0PIC (1.00)
Illumina Inc.USUnited StatesAssociated partnerEUR 0PIC (1.00)
Lgc Clinical Diagnostics IncUSUnited StatesParticipantEUR 0PIC (1.00)

Changes of the consortium

First seen on with 32 participants from 13 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.